BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38812296)

  • 21. Melatonin inhibits proliferation and viability and promotes apoptosis in colorectal cancer cells via upregulation of the microRNA-34a/449a cluster.
    Ji G; Zhou W; Li X; Du J; Li X; Hao H
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33398374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
    Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
    BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pristimerin inhibits proliferation, migration and invasion, and induces apoptosis in HCT-116 colorectal cancer cells.
    Yousef BA; Hassan HM; Guerram M; Hamdi AM; Wang B; Zhang LY; Jiang ZZ
    Biomed Pharmacother; 2016 Apr; 79():112-9. PubMed ID: 27044819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway.
    Guo X; Li Y; Chen X; Sun B; Guo X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):163. PubMed ID: 38546882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pimozide suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling pathway.
    Ren Y; Tao J; Jiang Z; Guo D; Tang J
    Life Sci; 2018 Sep; 209():267-273. PubMed ID: 30107167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRR11 Promotes Proliferation and Migration of Colorectal Cancer through Activating the EGFR/ERK/AKT Pathway via Increasing CTHRC1.
    Ma H; Yang W; Wang X; Dai G
    Ann Clin Lab Sci; 2022 Jan; 52(1):86-94. PubMed ID: 35181621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of profilin 1 as the primary target for the anti-cancer activities of Furowanin A in colorectal cancer.
    Zhao J; Xu J; Lv J
    Pharmacol Rep; 2019 Oct; 71(5):940-949. PubMed ID: 31454697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticolorectal Cancer Effects of AUCAN: Effects to Suppress Proliferation, Metastasis, and Invasion of Tumor Cells.
    Xiong LL; Du RL; Chen JJ; Jiang Y; Xue LL; Niu RZ; Chen L; Liu J; Wang TH
    Biomed Res Int; 2020; 2020():9786428. PubMed ID: 33102601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gambogic Acid Efficiently Kills Stem-Like Colorectal Cancer Cells by Upregulating ZFP36 Expression.
    Wei F; Zhang T; Yang Z; Wei JC; Shen HF; Xiao D; Wang Q; Yang P; Chen HC; Hu H; Chen ZP; Huang Q; Li WL; Cao J
    Cell Physiol Biochem; 2018; 46(2):829-846. PubMed ID: 29627822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymol Isolated from
    Zeng Q; Che Y; Zhang Y; Chen M; Guo Q; Zhang W
    Drug Des Devel Ther; 2020; 14():2535-2547. PubMed ID: 32669835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asiaticoside suppresses cell proliferation by inhibiting the NF‑κB signaling pathway in colorectal cancer.
    Zhou X; Ke C; Lv Y; Ren C; Lin T; Dong F; Mi Y
    Int J Mol Med; 2020 Oct; 46(4):1525-1537. PubMed ID: 32945376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-delivery of paclitaxel and cetuximab by nanodiamond enhances mitotic catastrophe and tumor inhibition.
    Lin YW; Raj EN; Liao WS; Lin J; Liu KK; Chen TH; Cheng HC; Wang CC; Li LY; Chen C; Chao JI
    Sci Rep; 2017 Aug; 7(1):9814. PubMed ID: 28852020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sonic hedgehog pathway activation is associated with cetuximab resistance and EPHB3 receptor induction in colorectal cancer.
    Park SH; Jo MJ; Kim BR; Jeong YA; Na YJ; Kim JL; Jeong S; Yun HK; Kim DY; Kim BG; Kang SH; Oh SC; Lee DH
    Theranostics; 2019; 9(8):2235-2251. PubMed ID: 31149041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo.
    Yang S; Li W; Sun H; Wu B; Ji F; Sun T; Chang H; Shen P; Wang Y; Zhou D
    BMC Cancer; 2015 Dec; 15():969. PubMed ID: 26674205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Wang P; Gao XY; Yang SQ; Sun ZX; Dian LL; Qasim M; Phyo AT; Liang ZS; Sun YF
    Drug Des Devel Ther; 2019; 13():2235-2247. PubMed ID: 31371920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
    Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB
    Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced anti-colorectal cancer effects of carfilzomib combined with CPT-11 via downregulation of nuclear factor-κB in vitro and in vivo.
    Tang W; Su G; Li J; Liao J; Chen S; Huang C; Liu F; Chen Q; Ye Y
    Int J Oncol; 2014 Sep; 45(3):995-1010. PubMed ID: 24968890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab.
    Ma H; Wu Z; Peng J; Li Y; Huang H; Liao Y; Zhou M; Sun L; Huang N; Shi M; Bin J; Liao Y; Rao J; Wang L; Liao W
    Int J Cancer; 2018 Jun; 142(12):2578-2588. PubMed ID: 29363109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.
    Liska D; Chen CT; Bachleitner-Hofmann T; Christensen JG; Weiser MR
    Clin Cancer Res; 2011 Feb; 17(3):472-82. PubMed ID: 21098338
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.